Latest Breaking News On - எங்களுக்கு ஆரோக்கியம் சீராக்கி - Page 1 : comparemela.com

Zydus Cadila gets tentative USFDA nod to market lung cancer drug PTI New Delhi | Updated on June 03, 2021 The drug to be manufactured at the group’s formulation manufacturing facility at SEZ, Ahmedabad Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market Osimertinib tablets, used to treat lung cancer. The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Osimertinib tablets in the strengths of 40 mg and 80 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing. Osimertinib is used to treat lung cancer. Osimertinib works by slowing or stopping the growth of cancer cells.

Zydus cadilaDrug administrationCadila healthcareTentative approvalUs health regulatorOsimertinib tabletsLung cancerAbbreviated new drug applicationsஜய்துச் காடிலாகாடிலா சுகாதாரம்எங்களுக்கு ஆரோக்கியம் சீராக்கிநுரையீரல் புற்றுநோய்